IN8bio Inc

NASDAQ:INAB 1:00:00 PM EDT

2.18

+0.02 (+0.93%)

4:57:17 PM EDT: $2.16 -0.02 (-0.92%)

IN8bio Inc Stock, NASDAQ:INAB

350 5th Avenue, Suite 5330, New York, New York 10118

United States of America

Phone: +1.646.600.6438

Number of Employees: 18

http://www.in8bio.com

Description

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.